{"entity":{"type":"insider","cik":"0001341896","url":"/insider/0001341896","json_url":"/insider/0001341896.json","name":"Fromkin Andrew J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":11,"first":"2006-08-29","last":"2026-05-29","span_basis":"filed_date"},"name_variants":[{"name":"Fromkin Andrew J.","source":"filing","n_filings":5,"first_seen":"2021-08-11","last_seen":"2026-05-29"},{"name":"Fromkin Drew J","source":"filing","n_filings":6,"first_seen":"2006-08-29","last_seen":"2008-11-12"}],"transactions":[{"id":5843641,"accession":"0001341896-26-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001341896-26-000004","line_url":"/filing/0001341896-26-000004","is_derivative":false,"issuer_cik":"0001341896","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001341896","owner_cik":"0001341896","owner_name":"Fromkin Andrew J.","owner_display_name":"Fromkin Andrew J.","owner_url":"/insider/0001341896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":221951.0,"shares_display":"221,951","price_per_share":33.512402286991275,"price_display":"33.51","price_state":"stated","total_value":7438111.2,"total_display":"7,438,111.20","total_whole":"7,438,111","shares_owned_after":74382.0,"shares_owned_after_display":"74,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-05-29","scope":"insider","n_lines":2},{"id":5099166,"accession":"0001764013-25-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000160","line_url":"/filing/0001764013-25-000160","is_derivative":false,"issuer_cik":"0001341896","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001341896","owner_cik":"0001341896","owner_name":"Fromkin Andrew J.","owner_display_name":"Fromkin Andrew J.","owner_url":"/insider/0001341896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22249.0,"shares_display":"22,249","price_per_share":23.245504966515348,"price_display":"23.25","price_state":"stated","total_value":517189.24,"total_display":"517,189.24","total_whole":"517,189","shares_owned_after":88750.0,"shares_owned_after_display":"88,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":5219191,"accession":"0001764013-25-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000034","line_url":"/filing/0001764013-25-000034","is_derivative":false,"issuer_cik":"0001341896","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001341896","owner_cik":"0001341896","owner_name":"Fromkin Andrew J.","owner_display_name":"Fromkin Andrew J.","owner_url":"/insider/0001341896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":19.59612,"price_display":"19.60","price_state":"stated","total_value":156768.96,"total_display":"156,768.96","total_whole":"156,769","shares_owned_after":93297.0,"shares_owned_after_display":"93,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider","n_lines":2},{"id":8379451,"accession":"0001764013-23-000156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001764013-23-000156","line_url":"/filing/0001764013-23-000156","is_derivative":false,"issuer_cik":"0001341896","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001341896","owner_cik":"0001341896","owner_name":"Fromkin Andrew J.","owner_display_name":"Fromkin Andrew J.","owner_url":"/insider/0001341896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12350.0,"shares_display":"12,350","price_per_share":39.73252793522267,"price_display":"39.73","price_state":"stated","total_value":490696.72,"total_display":"490,696.72","total_whole":"490,697","shares_owned_after":88658.0,"shares_owned_after_display":"88,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider","n_lines":3},{"id":4703799,"accession":"0001764013-21-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-21-000081","line_url":"/filing/0001764013-21-000081#line-1","is_derivative":false,"issuer_cik":"0001341896","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001341896","owner_cik":"0001341896","owner_name":"Fromkin Andrew J.","owner_display_name":"Fromkin Andrew J.","owner_url":"/insider/0001341896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":7.9,"price_display":"7.90","price_state":"stated","total_value":43450.0,"total_display":"43,450.00","total_whole":"43,450","shares_owned_after":45700.0,"shares_owned_after_display":"45,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-11","scope":"insider"},{"id":3919767,"accession":"0001209191-08-060054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-060054","line_url":"/filing/0001209191-08-060054#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.5648,"price_display":"9.56","price_state":"stated","total_value":19129.6,"total_display":"19,129.60","total_whole":"19,130","shares_owned_after":9405.0,"shares_owned_after_display":"9,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-12","scope":"insider"},{"id":9264366,"accession":"0001209191-07-069892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-069892","line_url":"/filing/0001209191-07-069892","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1880.0,"shares_display":"1,880","price_per_share":22.83563829787234,"price_display":"22.84","price_state":"stated","total_value":42931.0,"total_display":"42,931.00","total_whole":"42,931","shares_owned_after":4305.0,"shares_owned_after_display":"4,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-12","filed_date":"2007-12-14","scope":"insider","n_lines":5},{"id":7171264,"accession":"0001209191-07-069348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-07-069348","line_url":"/filing/0001209191-07-069348","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1880.0,"shares_display":"1,880","price_per_share":22.83563829787234,"price_display":"22.84","price_state":"stated","total_value":42931.0,"total_display":"42,931.00","total_whole":"42,931","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-12","filed_date":"2007-12-12","scope":"insider","n_lines":5},{"id":8137934,"accession":"0001209191-07-052267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-052267","line_url":"/filing/0001209191-07-052267#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":26.695,"price_display":"26.70","price_state":"stated","total_value":32034.0,"total_display":"32,034.00","total_whole":"32,034","shares_owned_after":2350.0,"shares_owned_after_display":"2,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-06","filed_date":"2007-09-06","scope":"insider"},{"id":5573589,"accession":"0001209191-06-064084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-064084","line_url":"/filing/0001209191-06-064084#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":16.6718,"price_display":"16.67","price_state":"stated","total_value":10836.67,"total_display":"10,836.67","total_whole":"10,837","shares_owned_after":1150.0,"shares_owned_after_display":"1,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-11","filed_date":"2006-12-11","scope":"insider"},{"id":9262188,"accession":"0001209191-06-048046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-048046","line_url":"/filing/0001209191-06-048046#line-1","is_derivative":false,"issuer_cik":"0000716646","issuer_name":"CLINICAL DATA INC","issuer_ticker":"CLDA","issuer_name_source":null,"issuer_url":"/issuer/0000716646","owner_cik":"0001341896","owner_name":"Fromkin Drew J","owner_display_name":"Fromkin Drew J","owner_url":"/insider/0001341896","role":"Officer (CEO, President)","role_mark":"O","role_mark_label":"Officer (CEO, President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":11.9,"price_display":"11.90","price_state":"stated","total_value":5950.0,"total_display":"5,950.00","total_whole":"5,950","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-21","filed_date":"2006-08-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Director","n_filings":5,"first_seen":"2021-08-11","last_seen":"2026-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000716646","name":"CLINICAL DATA INC","url":"/issuer/0000716646","role":"Director, Officer (CEO, President)","n_filings":6,"first_seen":"2006-08-29","last_seen":"2008-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341896","retrieved_at":"2026-08-22T12:51:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}